The Histone Deacetylase Inhibitor, Vorinostat, Blocks Growth and Associated Osteolysis of Cancer Cells within Bone, but Reduces Bone Volume in Non-Tumor Bearing Bones in Mice.

被引：0
|
作者：
Pratap, J. [1 ,2 ,3 ]
Dhillon, R. [4 ,5 ]
Li, X. [4 ,5 ]
Wixted, J. J. [1 ,2 ,3 ]
Akech, J. [1 ,2 ,3 ]
Bedard, K. [1 ,2 ,3 ]
Hussain, S. [1 ,2 ,3 ]
Colby, J. [1 ,2 ,3 ]
van Wijnen, A. J. [1 ,2 ,3 ]
Stein, J. L. [1 ,2 ,3 ]
Stein, G. S. [1 ,2 ,3 ]
Westendorf, J. J. [4 ,5 ]
Lian, J. B. [1 ,2 ,3 ]
机构：
[1] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Dept Orthoped Surg, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA
[4] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA
[5] Mayo Clin, Dept Mol Biol, Rochester, MN USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S442 / S442
页数：1
相关论文
共 9 条
  • [1] The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss
    Pratap, Jitesh
    Akech, Jacqueline
    Wixted, John J.
    Szabo, Gabriela
    Hussain, Sadiq
    McGee-Lawrence, Meghan E.
    Li, Xiaodong
    Bedard, Krystin
    Dhillon, Robinder J.
    van Wijnen, Andre J.
    Stein, Janet L.
    Stein, Gary S.
    Westendorf, Jennifer J.
    Lian, Jane B.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (12) : 3210 - 3220
  • [2] The histone deacetylase inhibitor, LBH589 blocks osteoclastogenesis, enhances osteoblast activity and reduces tumor burden in bone
    Lee, Michelle
    Labrinidis, Agatha
    Liapis, Vasilios
    Hay, Shelley
    Zinonos, Irene
    Butler, Lisa
    Ponomarev, Vladimir
    Findlay, David
    Evdokiou, Andreas
    CANCER RESEARCH, 2009, 69
  • [3] Bone marrow-derived cells contribute to tumor neovasculature and when modified to express an angiogenesis inhibitor, restrict tumor growth in mice.
    Davidoff, AM
    Leary, R
    Ng, CYC
    Spurbeck, W
    Brown, P
    Horwitz, EM
    Nienhuis, AW
    Vanin, EF
    BLOOD, 2000, 96 (11) : 804A - 804A
  • [4] Impact of vascular endothelial growth inhibitor (VEGI) on bone marrow derived endothelial progenitor cells in tumor bearing mice
    Liang, Paulina
    Tian, Fang
    Li, Luyuan
    CANCER RESEARCH, 2009, 69
  • [5] Prevention of tumor growth and tumor-induced osteolysis by the RANKL inhibitor osteoprotegerin (OPG) is associated with significant improvement in survival using a mouse model of breast cancer bone metastasis
    Canon, J.
    Roudier, M.
    Bryant, R.
    Radinsky, R.
    Dougall, W.
    BONE, 2007, 40 (06) : S145 - S145
  • [6] Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice
    Kim, SJ
    Uehara, H
    Karashima, T
    Shepherd, DL
    Killion, JJ
    Fidler, IJ
    CLINICAL CANCER RESEARCH, 2003, 9 (03) : 1200 - 1210
  • [7] Sequence-dependent synergistic antitumor interaction of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA, Vorinostat) in combination with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in non-small cell lung cancer cells
    Budillon, Alfredo
    Bruzzese, Francesca
    Di Gennaro, Elena
    Barbieri, Massimiliano
    Leone, Alessandra
    Caraglia, Michele
    CANCER RESEARCH, 2006, 66 (08)
  • [8] The RANKL inhibitor OPG-Fc, either alone or in combination with docetaxel, blocks lung cancer-induced osteolytic lesions and reduces skeletal tumor burden in a murine model of non-small cell lung cancer in bone
    Miller, R.
    Jones, J.
    Roudier, M.
    Dougall, W.
    BONE, 2010, 47 : S323 - S323
  • [9] MYELOPOIESIS-ASSOCIATED IMMUNE SUPPRESSOR CELLS IN MICE BEARING METASTATIC LEWIS LUNG-CARCINOMA TUMORS - GAMMA-INTERFERON PLUS TUMOR-NECROSIS-FACTOR-ALPHA SYNERGISTICALLY REDUCES IMMUNE SUPPRESSOR AND TUMOR GROWTH-PROMOTING ACTIVITIES OF BONE-MARROW CELLS AND DIMINISHES TUMOR RECURRENCE AND METASTASIS
    YOUNG, MRI
    WRIGHT, MA
    CANCER RESEARCH, 1992, 52 (22) : 6335 - 6340
1